| Date: |
Thursday, November 26, 2015
|
| Time: |
11:00 - 17:00, followed by drinks
|
| Location: |
Seminar Room HG00.071, Huygens building, Faculty of Science, Heyendaalseweg 135
|
| Registration: |
Free. Deadline November 24; register here
|
Organizer: NeuroInformatics.NL; program committee Marijn Martens, Rembrandt Bakker, Paul Tiesinga
Introduction
Most brain diseases have multifactorial underlying causes of small-effect size and often result in a large variability in the patient group. Therefore, individuals with a brain disease will benefit from personalized health care. The aim of personalized health care is to improve the accuracy of diagnosis, prognosis and treatment based on personal qualitative and quantitative traits. Recent technological advancements, such as genetic profiling, brain scans and smart wearable devices that yield large and complex data sets, allow novel ways of measuring and monitoring patients, but remain underutilized. During this symposium we will discuss how these technologies can be integrated and used for personalized health care. Business and science will meet to see if these technologies can be applied to achieve predictive value that is beyond the existing diagnostic and prognostic testing methods.
Program
morning session:
11:00: welcome coffee
11:10: Marijn Martens: Introduction
11:15: [confirmed speaker] Keynote speaker Prof. Paul Matthews, Division of Brain Sciences, Imperial College London & Chair of the Imaging Working Group for UK Biobank.
Title: “500,000 UK contributors to research on genes, brain scans and health”.
12:00: [confirmed speaker] Dr. Charlotte Teunissen, Head Neurochemistry Lab and Biobank, Program Director Parelsnoer VUmc, Neurocampus VU University Medical Center Amsterdam.
Title "Body fluid biomarkers as a useful tool for personalized diagnosis and therapy in Multiple Sclerosis and Alzheimer's disease".
12:25: [confirmed speaker] Dr. Wim van Hecke, co-founder Icometrix - MRI imaging biomarker experts, Leuven, Belgium.
Title: "From many to one - MRI biomarkers for follow-up of patients with Multiple Sclerosis".
12:50: lunch
afternoon session:
14:00: [confirmed speaker] Keith Baker, Director for Divisional Partnerships; Philips Group Innovation.
Title: "Personal Genomics and Cognitive Decline: just APOE4-4?"
14:30: [confirmed speaker] Dr. Kees Albers, Department of Human Genetics, Radboud UMC Nijmegen.
Title: "Statistical data integration of epigenetic studies in human iPSC-derived neurons and genetic association studies to identify dysregulated pathways in neurodevelopment”.
14:50: Dr. Geert Poelmans, co-founder and director of DrugTargetID.
Title: "Identifying drug targets and (repurposed) disease-modifying compounds through building molecular landscapes for complex genetic disorders".
15:10: short break
15:25: [confirmed speaker] Prof. Alain van Gool, Professor personalized healthcare, Radboudumc and Applied biomarker scientist, TNO.
Title: “Personalized Health(care): more than just targeted medicines”.
15:45: [confirmed speaker] Keith Baker, Director for Divisional Partnerships; Philips Group Innovation.
Title: “Wearables and the hidden neurological pathways and conditions".
16:00: [confirmed speaker] Dr. Maarten van der Heijden, Institute for Computing and Information Sciences, Radboud University Nijmegen.
Title: “Patient support with smart mHealth technology”.
16:20: [confirmed speaker] Dr. Nick Guldemond, Integrated Care & Technology and Chief Innovation Officer, UMC Utrecht.
Title: “Challenges in realising personalized health care from an integrated health care perspective".
16:30: Forum: current status and future perspectives of personalized health care.
17:00: drinks
Admission:
Free
